• 原料药

    product
  • 产品目录
    Name
    Chemical Name
    Cas No.
    Key Intermediates
    (Cas No.)
    Status
    Indication
    Purity or Assay
    沙格列汀 Saxagliptin 945667-22-1 361440-67-7 709031-45-8 CFDA USFDA Ⅱ型糖尿病 98.0%~102.0%
    枸橼酸托法替布 Tofacitinib Citrate 540737-29-9 3680-69-1 479633-63-1 Lab completed JAK通路抑制剂;类风湿性关节炎 98.0%~102.0%
    恩曲他滨 Emtricitabine 143491-57-0 147126-75-8 2022-85-7 147126-62-3 USFDA WHO HIV-1、乙肝 ≥98.5%
    他扎罗汀 Tazarotene 118292-40-3 NA CFDA 用于治疗银屑病、痤疮,并用于角化异常性疾病、毛囊皮脂腺疾病、皮肤癌前期病变 98.5%~101.5%
    替格瑞洛 Ticagrelor 274693-27-5 51336-95-9 376608-71-8 376608-65-0 Lab completed 用于急性冠脉综合征 ≥99.0%
    (8-[2-羟基苯甲酰基]-氨基)辛酸钠 Salcaprozate Sodium 203787-91-1 NA Developing 口服吸收促进剂 ≥99%
    雷诺嗪 Ranolazine 95635-55-5 2210-74-4; 1131-01-7; 5294-61-1; Developing 治疗慢性心绞痛药 ≥99%
    甲磺酸达比加群酯 Dabigatran Etexilate Mesylate; Pradaxa 872728-81-9 212322-56-0 Lab completed 抗凝血药物 98.0%~102.0%
    上一页1下一页 转至第